Trials / Completed
CompletedNCT01257919
Safety and Pharmacokinetics of Azelaic Acid Foam, 15% in Papulopustular Rosacea
Investigator-blinded, Randomized, Cross-over, Multiple Dose Phase I Study on Safety and Pharmacokinetics of Topically Applied Azelaic Acid Foam, 15% Compared to Azelaic Acid Gel, 15% in Subjects With Papulopustular Rosacea
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 21 (actual)
- Sponsor
- LEO Pharma · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Assessment of pharmacokinetics of Azelaic Acid Foam after repeated skin application and in comparison to Azelaic Acid gel. Assessment of safety after repeated skin application.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Azelaic Acid Foam | Dermal application of Azelaic Acid Foam |
| DRUG | Azelaic Acid Gel | Dermal application of Azelaic Acid Gel |
Timeline
- Start date
- 2011-01-01
- Primary completion
- 2011-03-01
- Completion
- 2011-03-01
- First posted
- 2010-12-10
- Last updated
- 2023-06-09
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01257919. Inclusion in this directory is not an endorsement.